Supernus Pharmaceuticals reported $53K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Adamas Pharmaceuticals ADMS:US 50K 0
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Ani Pharmaceuticals ANIP:US $ 0M 0M
Antares Pharma ATRS:US $ 1.7M 0.01M
Aphria Inc APH:CN C$ 2.08B 830K
Aurora Cannabis Inc ACB:CN 6.42B 9.78M
Bristol Myers Squibb BMY:US $ 292M 0M
Canopy Growth Corp WEED:CN C$ 7.46B 295M
Cara Therapeutics CARA:US $ 50K 0
Corcept Therapeutics CORT:US $ 0.12M 0M
Eisai 4523:JP Y 44986M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Endo International Ordinary Shares ENDP:US $ 0.07M 0M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Horizon Pharma HZNP:US $ 0.02M 0M
JAZZ PHA JAZZ:US $ 0.06M 0M
Lannett LCI:US $ 0.04M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Pacira Pharmaceuticals PCRX:US $ 0.04M 0M
Perrigo Ordinary Shares PRGO:US $ 7081.7M 19.6M
Revance Therapeutics RVNC:US $ 0.07M 0M
Supernus Pharmaceuticals SUPN:US $ 0.05M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Xeris Pharmaceuticals Inc XERS:US $ 7K 0